v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2024 $ 99,644 $ 94 $ 386,534 $ 61 $ (287,045)
Beginning Balance (in shares) at Dec. 31, 2024   93,602,631      
Stock-based compensation 1,208   1,208    
Issuance of common stock from exercise of stock options 718   718    
Issuance of common stock from exercise of stock options (in shares)   290,284      
Issuance of common stock from warrant exercise 8,220 $ 6 8,214    
Issuance of common stock from warrant exercise (in shares)   6,000,000      
Issuance of common stock under offering, less issuance costs (5)   (5)    
Unrealized gains (losses) on available-for-sale marketable securities 12     12  
Net loss (10,340)       (10,340)
Ending Balance at Mar. 31, 2025 99,457 $ 100 396,669 73 (297,385)
Ending Balance (in shares) at Mar. 31, 2025   99,892,915      
Beginning Balance at Dec. 31, 2025 183,244 $ 128 512,772 (148) (329,804)
Beginning Balance (in shares) at Dec. 31, 2025   128,306,056      
Stock-based compensation 2,191   2,191    
Issuance of common stock from exercise of stock options $ 222   222    
Issuance of common stock from exercise of stock options (in shares) 104,992 104,992      
Unrealized gains (losses) on available-for-sale marketable securities $ (338)     (338)  
Net loss (13,192)       (13,192)
Ending Balance at Mar. 31, 2026 $ 172,127 $ 128 $ 515,185 $ (190) $ (342,996)
Ending Balance (in shares) at Mar. 31, 2026   128,411,048